Vivani Medical Inc
VANI
Get informed when a big investor buys or sells
+ FollowMarket Cap$109.52M
Close$
$-0.04
103.3% downside
Current Fair Value
103.3% downsideOvervalued by 103.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $109.52 Million |
|---|---|
| Enterprise Value | $107.48 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.43 |
| Beta | 3.28 |
| Outstanding Shares | 87,090,000 |
Return
| Return on Equity | -138.73% |
|---|---|
| Return on Assets | -63.19% |
| Return on Invested Capital | -79.33% |
Valuation & Multiples
| P/E Ratio | -3.63 |
|---|---|
| PEG | 33.49 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -3.87 |
| Enterprise Value to Net Income | -5 |
| Total Debt to Enterprise | 0.17 |
| Debt to Equity | 0.94 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 18, 2026
EPS Estimate
$-0.08
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
November 12, 2026
EPS Estimate
$-0.07
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 5.99%▼ 0.91% |
|---|---|
| Total Invested | $6.47M▲ 15.33% |
| Investors Holding | 38▼ 6.00% |
ESG Score
No data
About Vivani Medical Inc
12 employeesSecond Sight Medical Products, Inc. (NASDAQ: EYES) develops, manufactures and markets implantable visual prosthetics that are intended to deliver useful artificial vision to blind individuals. A recognized global leader in neuromodulatio...